Cardiac Guidance vs Zio AT ECG Monitoring System
AI Verdict
Choose Cardiac Guidance if…
Choose Caption Health's Cardiac Guidance if you need to perform immediate, diagnostic-quality cardiac ultrasound assessments at the point of care, especially when an expert sonographer is not readily available. This tool is ideal for empowering non-expert ultrasound users, such as emergency physicians or primary care providers, to acquire and interpret critical cardiac images with real-time AI guidance and automated quality checks.
View Cardiac Guidance →Choose Zio AT ECG Monitoring System if…
Choose the Zio AT ECG Monitoring System if your primary goal is long-term, continuous ECG monitoring for the detection of intermittent or elusive cardiac arrhythmias. This wearable system is best suited for patients requiring extended monitoring (up to 14 days) to capture symptomatic or asymptomatic events that might be missed by shorter-duration tests, providing comprehensive data for diagnosis and management remotely.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | Cloud-based (data analytics and clinician portal) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceCardiac Guidance (Tool A) offers real-time AI guidance, turn-by-turn probe movement instructions, and automated quality assessment, specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality images. This significantly lowers the barrier to performing complex cardiac ultrasounds, making it highly user-friendly in a clinical setting. While Zio AT (Tool B) provides patient convenience with a wearable patch and mobile apps, its impact on simplifying a complex medical procedure is less pronounced than Tool A's democratization of ultrasound acquisition.
Clinical Value
TieBoth tools offer significant, yet distinct, clinical value. Cardiac Guidance (Tool A) democratizes access to diagnostic-quality cardiac ultrasound at the point of care, including automated EF calculation, addressing sonographer shortages and expanding early detection of structural heart disease. Zio AT (Tool B) provides continuous, long-term (up to 14 days) AI-powered ECG monitoring for comprehensive arrhythmia detection, crucial for identifying transient or asymptomatic events that might otherwise be missed. Their applications are complementary, each addressing a critical need in cardiac care.
Pricing & Value
Zio AT ECG Monitoring SystemWhile both tools require direct vendor contact for enterprise pricing, Zio AT (Tool B) offers more transparency regarding patient-level costs and a robust direct-bill program to insurance, alongside patient assistance programs, discounted self-pay options, and installment plans. Cardiac Guidance (Tool A) has secured CMS NTAP status, which benefits hospitals by reimbursing costs for Medicare patients, but its core software pricing remains largely undisclosed, and the publicly mentioned $299 price is for a direct-to-patient service, not the enterprise solution.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Cardiac Guidance (Tool A) integrates as a software accessory with compatible diagnostic ultrasound systems and benefits from being acquired by GE HealthCare, enhancing its market reach and integration potential within imaging departments. Zio AT (Tool B) offers a scalable cloud-based deployment with clinician portals and EHR integration, providing robust infrastructure for remote monitoring programs and data management. Each is well-prepared for enterprise adoption through different deployment and integration strategies.
Innovation
Cardiac GuidanceCardiac Guidance (Tool A) represents a more foundational innovation by using AI to guide non-expert users in real-time to acquire diagnostic-quality cardiac ultrasound images, effectively democratizing a highly skilled and operator-dependent procedure. This addresses a significant workforce shortage and expands access to critical diagnostic imaging. While Zio AT (Tool B) is innovative in its long-term wearable ECG monitoring and AI-powered arrhythmia detection, Tool A's impact on skill transfer and immediate diagnostic capability at the point of care is arguably more transformative.
Support & Docs
Zio AT ECG Monitoring SystemZio AT (Tool B) provides extensive support, including 24/7 patient support via phone and email, a MyZio patient mobile app with symptom logging and educational content, and a ZioSuite clinician portal with comprehensive resources. Dedicated patient advocates also assist with billing and payment options. Cardiac Guidance (Tool A) offers an electronic operator's manual and GE HealthCare customer service, but the breadth and accessibility of its support channels appear less detailed in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | Zio AT ECG Monitoring System |
|---|---|---|
| Name | Cardiac Guidance | Zio AT ECG Monitoring System |
| Company | Caption Health | iRhythm Technologies, Inc. |
| Description | FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
| Key Features | Real-time AI guidance for cardiac ultrasound image acquisition; Turn-by-turn on-screen probe movement instructions; Automated quality assessment with a 'Quality Meter'; Auto-capture of diagnostic-quality images and video clips; Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation); Support for 10 standard echocardiographic views (e.g., PLAX, AP4, AP2); Compatibility with point-of-care ultrasound systems; Designed for use by non-expert ultrasound users | Wearable Zio AT patch for continuous ECG recording; Wireless gateway for real-time data transmission; FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection; Continuous, uninterrupted ECG recording for up to 14 days; Detection of symptomatic and asymptomatic cardiac events; Comprehensive end-of-wear reports for clinicians; ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation; MyZiou00ae patient mobile app for symptom logging and education |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Cardiac Guidance or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.